Related Experiment Video
Updated: Jul 18, 2026
11:10
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
Published on: December 27, 2010
Summary
Dr. Saye Khoo researches HIV and TB drug pharmacokinetics, focusing on intracellular accumulation, drug resistance, and interactions. His work aims to optimize HIV therapy through therapeutic drug monitoring and pharmacogenomics.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Dr. Saye Khoo, based at the University of Liverpool, is a leading expert in pharmacology and infectious diseases.
- His clinical roles include Honorary Consultant in Infectious Diseases and lead clinician for significant HIV care networks.
- He has contributed to influential committees and journals, shaping treatment guidelines and antimicrobial chemotherapy.
Discussion:
- Research focuses on the intracellular accumulation of Human Immunodeficiency Virus (HIV) drugs and the role of drug transporters.
- Investigates the evolution of HIV resistance in sanctuary sites and analyzes drug-drug interactions.
- Explores therapeutic drug monitoring and the pharmacogenomics of HIV therapy to personalize treatment.
Key Insights:
- Understanding intracellular drug concentrations is crucial for effective HIV treatment.
- Drug transporters significantly influence HIV drug efficacy and resistance development.
- Pharmacogenomics offers potential for tailoring HIV therapies to individual patient profiles.
Outlook:
- Further research into TB drug sterilizing activity parallels HIV drug investigations.
- Optimizing therapeutic drug monitoring and pharmacogenomic approaches can improve patient outcomes.
- Continued exploration of drug interactions and resistance mechanisms is vital for managing infectious diseases.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...